← Eichor
Condition: Leiomyosarcoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Leiomyosarcoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT07467772Localized Leiomyosarcoma Biomarker Protocol
Phase N/A · 3 location(s) · University of Michigan Rogel Cancer Center · NCT04925089Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
Phase 2 · 1 location(s) · Gabriel Tinoco · NCT06528769Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
Phase N/A · 1 location(s) · University of Utah · NCT06875700A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
Phase N/A · 40 location(s) · Federation Francophone de Cancerologie Digestive · NCT06541652Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma
Phase N/A · 10 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT06749600Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06170177IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)
Phase 2 · 1 location(s) · Fudan University · NCT06849986Letrozole in Uterine Leiomyosarcoma
Phase 2 · 25 location(s) · GOG Foundation · NCT05649956Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
EARLY_Phase 1 · 1 location(s) · University of California, Irvine · NCT07628634Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Ris
Phase 2 · 25 location(s) · UNICANCER · NCT06524583Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
Phase 1/Phase 2 · 17 location(s) · Grupo Espanol de Investigacion en Sarcomas · NCT02275286A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcoma
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06308419Metastatic Leiomyosarcoma Biomarker Protocol
Phase N/A · 11 location(s) · University of Michigan Rogel Cancer Center · NCT05653388Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tis
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06498648Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (AP
Phase 3 · 24 location(s) · Advenchen Laboratories, LLC · NCT03016819Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
NA · 16 location(s) · Centre Leon Berard · NCT04055220Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Adv
Phase 1 · 16 location(s) · National Cancer Institute (NCI) · NCT05711615Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma
Phase 2 · 17 location(s) · Italian Sarcoma Group · NCT04383119Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.
Phase 2 · 2 location(s) · Oslo University Hospital · NCT07173972Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Phase 1 · 1 location(s) · Washington University School of Medicine · NCT06957431NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and S
Phase 1/Phase 2 · 7 location(s) · St. Jude Children's Research Hospital · NCT06239272Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168A Study of Ivonescimab in People With Leiomyosarcoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07516925STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants
Phase 1/Phase 2 · 9 location(s) · STORM Therapeutics LTD · NCT06975293Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Phase 1 · 10 location(s) · Epkin · NCT06789172AOH1996 for the Treatment of Refractory Solid Tumors
Phase 1 · 3 location(s) · City of Hope Medical Center · NCT05227326Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
Phase 2 · 1 location(s) · University of Colorado, Denver · NCT07125183Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma
Phase 2 · 1 location(s) · Sarcoma Oncology Research Center, LLC · NCT04535271
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.